Literature DB >> 14689190

[Liver replacement therapy. Reliable indications in acute liver failure].

K Rifai1, M Ott, M M Bahr, A Schneider, M P Manns.   

Abstract

Extracorporeal liver support devices aim at improving the therapeutical options for liver failure. Numerous artificial and bioartificial devices have been tested to reduce the high mortality of this dynamic disease. In particular, the detoxification function of the liver should be upheld, by means of a number of different procedures, either until liver function is restored or until transplantation. Both purely artificial, machine-based procedures including different forms of dialysis and hemoadsorption as well as bioartificial procedures based on hepatocytes are being tested, as are different types of extracorporeal liver perfusion. This paper provides an overview of the different methods and devices and their clinical evidence in order to give a recommendation for the handling of the expensive devices. There is no current indication for the application of liver support devices outside of clinical studies at specialised centres.

Entities:  

Mesh:

Year:  2003        PMID: 14689190     DOI: 10.1007/s00108-003-1076-4

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  32 in total

Review 1.  Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review.

Authors:  Lise L Kjaergard; Jianping Liu; Bodil Als-Nielsen; Christian Gluud
Journal:  JAMA       Date:  2003-01-08       Impact factor: 56.272

Review 2.  Extracorporeal albumin dialysis in acute-on-chronic liver failure: will it stand the test of time?

Authors:  Sambit Sen; Rajiv Jalan; Roger Williams
Journal:  Hepatology       Date:  2002-10       Impact factor: 17.425

3.  Fractionated plasma separation and adsorption system: a novel system for blood purification to remove albumin bound substances.

Authors:  D Falkenhagen; W Strobl; G Vogt; A Schrefl; I Linsberger; F J Gerner; M Schoenhofen
Journal:  Artif Organs       Date:  1999-01       Impact factor: 3.094

4.  Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure.

Authors:  A J Ellis; R D Hughes; J A Wendon; J Dunne; P G Langley; J H Kelly; G T Gislason; N L Sussman; R Williams
Journal:  Hepatology       Date:  1996-12       Impact factor: 17.425

5.  Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial.

Authors:  F D Watanabe; C J Mullon; W R Hewitt; N Arkadopoulos; E Kahaku; S Eguchi; T Khalili; W Arnaout; C R Shackleton; J Rozga; B Solomon; A A Demetriou
Journal:  Ann Surg       Date:  1997-05       Impact factor: 12.969

6.  Bioreactor for a larger scale hepatocyte in vitro perfusion.

Authors:  J C Gerlach; J Encke; O Hole; C Müller; C J Ryan; P Neuhaus
Journal:  Transplantation       Date:  1994-11-15       Impact factor: 4.939

7.  MARS (Molecular Adsorbent Recirculating System): experience in 34 cases of acute liver failure.

Authors:  Gilnardo Novelli; Massimo Rossi; Renzo Pretagostini; Luca Poli; Luigi Novelli; Pasquale Berloco; Giancarlo Ferretti; Massimo Iappelli; Raffaello Cortesini
Journal:  Liver       Date:  2002

8.  Modular extracorporeal liver support.

Authors:  Igor M Sauer; Joerg C Gerlach
Journal:  Artif Organs       Date:  2002-08       Impact factor: 3.094

9.  Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure.

Authors:  J G O'Grady; A E Gimson; C J O'Brien; A Pucknell; R D Hughes; R Williams
Journal:  Gastroenterology       Date:  1988-05       Impact factor: 22.682

Review 10.  Extracorporeal liver perfusion as hepatic assist in acute liver failure: a review of world experience.

Authors:  Andreas Pascher; Igor M Sauer; Claus Hammer; Joerg C Gerlach; Peter Neuhaus
Journal:  Xenotransplantation       Date:  2002-09       Impact factor: 3.907

View more
  1 in total

1.  Fulminant hepatic failure following marijuana drug abuse: Molecular adsorbent recirculation system therapy.

Authors:  G Swarnalatha; S Pai; R Ram; K V Dakshinamurty
Journal:  Indian J Nephrol       Date:  2013-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.